Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty
✍ Scribed by Helft, Gérard ;Choktron, Sylvie ;Beygui, Farzyn ;Le Feuvre, Claude ;Elalamy, Ismail ;Metzger, Jean-Philippe ;Vacheron, André ;Samama, Michel Meyer
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 52 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0098-6569
No coin nor oath required. For personal study only.
✦ Synopsis
The aim of this study was to compare the activated clotting time (ACT) obtained with the Hemochron device and the Heparin Management Test (HMT) on a new automated whole-blood coagulometer, the Thrombolytic Assessment System, in patients undergoing angioplasty. Fifty patients undergoing balloon angioplasty were prospectively enrolled. The mean ACT after a 10,000 unit bolus of heparin was 283 ؎ 39 sec at the end of the procedure. The mean HMT after 10,000 units of heparin was 286 ؎ 31 sec at the end of the procedure in the same patients. The correlation between the two methods was significant (r ؍ 0.6; P F 0.01). The HMT appears to correlate well with standard values obtained with the Hemochron ACT monitor in patients undergoing percutaneous transluminal coronary angioplasty.